Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001070698-14-000025
Filing Date
2014-05-09
Accepted
2014-05-08 20:26:43
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q Q1-2014 FOR THE THREE MONTHS ENDED MARCH 31, 2014 rptp050814_q114_033114_10q.htm 10-Q 791879
2 CEO CERTIFICATION rptp_exh311.htm EX-31.1 10137
3 CFO CERTIFICATION rptp_exh312.htm EX-31.2 9971
4 CEO AND CFO CERTIFICATION rptp_exh321.htm EX-32.1 10120
  Complete submission text file 0001070698-14-000025.txt   5160341

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rptp-20140331.xml EX-101.INS 681647
6 XBRL TAXONOMY EXTENSION SCHEMA rptp-20140331.xsd EX-101.SCH 39191
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rptp-20140331_cal.xml EX-101.CAL 52857
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rptp-20140331_def.xml EX-101.DEF 127758
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptp-20140331_lab.xml EX-101.LAB 500881
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptp-20140331_pre.xml EX-101.PRE 268624
Mailing Address 5 HAMILTON LANDING SUITE 160 NOVATO CA 94949
Business Address 5 HAMILTON LANDING SUITE 160 NOVATO CA 94949 415-408-6200
Raptor Pharmaceutical Corp (Filer) CIK: 0001070698 (see all company filings)

EIN.: 860883978 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-25571 | Film No.: 14826716
SIC: 2834 Pharmaceutical Preparations